Opioids, Reward and Addiction: An Encounter of Biology ...

390 VAN REE ET AL.
motivation: Neurobiological evidence from studies of opiate dependence. Neurosci
Biobehav Rev 13:135–140.
Koob GF, Wall TL and Bloom FE (1989b) Nucleus accumbens as a substrate for the
aversive stimulus effects of opiate withdrawal. Psychopharmacology 98:530–534.
Kornet M, Goosen C, Thyssen JH and Van Ree JM (1992a) Endocrine profile during
acquisition of free-choice alcohol drinking in rhesus monkeys; treatment with
desglycinamide-(Arg 8 )-vasopressin. Alcohol Alcohol 27:403–410.
Kornet M, Goosen C and Van Ree JM (1990) The effect of interrupted alcohol supply
on spontaneous alcohol consumption by rhesus monkeys. Alcohol Alcohol 4:407–
412.
Kornet M, Goosen C and Van Ree JM (1991) Effect of naltrexone on alcohol consumption
during chronic alcohol drinking and after a period of imposed abstinence
in free-choice drinking rhesus monkeys. Psychopharmacology 104:367–376.
Kornet M, Goosen C, Van Ree JM and Van Vlaardingen JAM (1992b) Low doses of
morphine reduce voluntary alcohol drining in rhesus monkeys. Eur Neuropsychopharmacol
2:73–86.
Kornetsky C and Bain G (1983) Effects of opiates on rewarding brain stimulation, in
The Neurobiology of Opiate Reward Processes (Smith JE and Lane JD eds) pp
237–253, Elsevier Biomedical Press, Amsterdam.
Kornetsky C, Bain and Riedl M (1981a) Effects of cocaine and naloxone on brainstimulation
reward. Pharmacologist 23:192.
Kornetsky C and Esposito RU (1979) Euphorigenic drugs: Effects on the reward
pathways of the brain. Fed Proc 38:2473–2476.
Kornetsky C, Esposito RU, McLean S and Jacobson JO (1979) Intracranial selfstimulation
thresholds: A model for the hedonic effects of drugs of abuse. Arch Gen
Psychiatry 36:289–292.
Kornetsky C, Markowitz RA and Esposito RU (1981b) Phencyclidine and Naloxone:
Effects on sensitivity to aversive and rewarding stimulation in the rat, in PCP
(Phencyclidine): Historical and Current Perspectives (Domino F ed) pp 321–330,
NPP Books, Ann Arbor, MI.
Kosten T, Silverman DG, Fleming J, Kosten TA, Gawin FH, Compton M, Jatlow P
and Byck R (1992) Intravenous cocaine challenges during naltrexone maintenance:
A prelimenary study. Biol Psychiatry 32:543–548.
Kosten TA (1994) Clonidine attenuates conditioned aversion produced by naloxoneprecipitated
opiate withdrawal. Eur J Pharmacol 254:59–63.
Kosten TA, Marby DW and Nestler EJ (1991) Cocaine conditioned place preference
is attenuated by chronic buprenorphine treatment. Life Sci 49:PL201–PL206.
Kosterlitz HW and Waterfield AA (1975) In vitro models in the study of structureactivity
relationships of narcotic analgesics. Annu Rev Pharmacol 15:29–47.
Kratzer U and Schmidt WJ (1998) The anti-craving drug acamprosate inhibits the
conditioned place aversion induced by naloxone-precipitated morphine withdrawal
in rats. Neurosci Lett 252:53–56.
Krishnan-Sarin S, Jing SL, Kurtz DL, Zweifel M, Portoghese PS, Li TK and Froehlich
JC (1995a) The -opioid receptor antagonist naltrindole attenuates both alcohol
and saccharin intake in rats selectively bred for alcohol preference. Psychopharmacology
120:177–185.
Krishnan-Sarin S, Portoghese PS, Li TK and Froehlich JC (1995b) The delta 2-opioid
receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for
alcohol preference. Pharmacol Biochem Behav 52:153–159.
Kruszewska A, Romandini S and Samanin R (1986) Different effects of zimelidine on
the reinforcing properties of d-amphetamine and morphine on conditioned place
preference in rats. Eur J Pharmacol 125:283–286.
Kuzmin A, Martelotta MC, Fratta W, Gessa GL and Zvartau E (1996a) Effect of
isradipine, a dihydropyridine-calcium antagonist on I.V. self-administration of
morphine in rats. Life Sci 59:159–164.
Kuzmin A, Patkina N, Pchelintsev M and Zvartau E (1992a) Inradipine is able to
separate morphine-induced analgesia and place conditioning. Brain Res 593:221–
225.
Kuzmin A, Zvartau E, Gessa GL, Martelotta MC and Fratta W (1992b) Calcium
antagonists isradipine and nimodipine suppress cocaine and morphine intravenous
self-administration in drug-naive mice. Pharmacol Biochem Behav 41:497–
500.
Kuzmin A, Semenova S, Ramsey N, Zvartau E and Van Ree JM (1996b) Modulation
of cocaine intravenous self-administration in drug-navie animals by dihydropyridine
Ca 2 channel modulators. Eur J Pharmacol 295:19–25.
Kuzmin A, Semenova S, Zvartau EE and Van Ree JM (1996c) Enhancement of
morphine self-administration in drug naive, inbred strains of mice by acute emotional
stress. Eur Neuropsychopharmacol 6:63–68.
Kuzmin AV, Gerrits MAFM and Van Ree JM (1998) -Opioid receptor-blockade with
nor-binaltorphimine modulates cocaine self-administeration in drug-naive rats.
Eur J Pharmacol 358:197–202.
Kuzmin AV, Gerrits MAFM, Van Ree JM and Zvartau EE (1997a) Naloxone inhibits
the reinforcing and motivational aspects of cocaine addiction in mice. Life Sci
60:PL257–PL264.
Kuzmin AV, Patkina N and Zvartau E (1994) Analgesic and reinforcing effects of
morphine in mice. Influence of Bay K-8644 and nimodipine. Brain Res 652:1–8.
Kuzmin AV, Semenova S, Gerrits MAFM, Zvartau EE and Van Ree JM (1997b)
-Opioid receptor agonist U50,488H modulates cocaine and morphine selfadministration
in drug-naive rats and mice. Eur J Pharmacol 321:265–271.
Lachowitz JE, Shen Y, Monsma FJ Jr and Sibley DR (1995) Molecular cloning of a
novel G protein-coupled receptor related to the opiate receptor family. J Neurochem
64:34–40.
LaGasse JM, Wetstein LM, Czirr SA and Reid LD (1987) Morphine and diprenorphine
together potentiate responding for positively reinforcing brain stimulation.
Psychobiology 15:261–264.
Lang WJ, Latiff AA, McQueen A and Singer G (1977) Self-administration of nicotine
with and without food delivery schedule. Pharmacol Biochem Behav 7:65–70.
Lasagna L (1965) Drug interaction in the field of analgesic drugs. Proc R Soc Med
58:978–983.
Layer RT, Uretsky NJ and Wallace LJ (1993) Effects of the AMPA/kainate receptor
antagonist DNQX in the nucleus accumbens on drug-induced conditioned place
preference. Brain Res 617:267–273.
Leander JD, McMillan DE and Harris LS (1975) Schedule-induced oral narcotic
self-administration: acute and chronic effects. J Pharmacol Exp Ther 195:279–
287.
Leone P and Di Chiara G (1987) Blockade of D-1 receptors by SCH 23390 antagonizes
morphine- and amphetamine-induced place preference conditioning. Eur J Pharmacol
135:251–254.
Leone P, Poddock D and Wise RA (1991) Morphine-dopamine interaction: ventral
tegmental morphine increases nucleus accumbens dopamine release. Pharmacol
Biochem Behav 39:469–472.
Le Pen G, Duterte-Boucher D and Costentin J (1998) Sensitization to the rewarding
effects of the specific dopamine uptake inhibitor GBR12783. J Pharmacol Exp
Ther 286:688–696.
Lepore M, Liu X, Savage V, Matalon D and Gardner EL (1996) Genetic differences in
9 -tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured
by a rate-frequency curve-shift electrical brain stimulation paradigm in
three different rat strains. Life Sci 58:PL365–PL372.
Leshner AI (1997) Addiction is a brain disease, and it matters. Science (Wash DC)
278:45–47.
Lett BT (1989) Repeated exposures intensify rather than diminish the rewarding
effects of amphetamine, morphine, and cocaine. Psychopharmacology 98:357–362.
Lewis MJ and June HL (1994) Synergistic effects of ethanol and cocaine on brain
stimulation reward. J Exp Anal Behav 61:223–229.
Li SJ, Jiang HK, Stachowiak MS, Hudson PM, Owyang V, Nanry K, Tilson HA and
Hong JS (1990) Influence of nigrostriatal dopaminergic tone on the biosynthesis of
dynorphin and enkephalin in rat striatum. Mol Brain Res 8:219–219 167 .
Li SJ, Sivam SP and Hong JS (1986) Regulation of the concentration of dynorphin A
1–8 in the striatonigral pathway by the dopaminergic system. Brain Res 398:390–
392.
Li SJ, Sivam SP, McGinty JF, Jiang HK, Douglass J, Calavetta L and Hong JS (1988)
Regulation of the metabolism of striatal dynorphin by the dopaminergic system.
J Pharmacol Exp Ther 246:403–408.
Liebman J and Segal DS (1977) Differential effects of morphine and D-amphetamine
on self-stimulation from closely adjacent regions in rat midbrain. Brain Res 136:
103–117.
Lightman SL and Young WSI (1987) Changes in hypothalamic preproenkephalin A
mRNA following stress and opiate withdrawal. Nature (Lond) 328:643–645.
Linseman MA (1989) Central versus peripheral mediation of opioid effects on alcohol
consumption in free-feeding rats. Pharmacol Biochem Behav 33:407–413.
Linseman MA and Harding S (1990) Intracerebroventricular morphine enhances
alcohol consumption by rats. Pharmacol Biochem Behav 36:405–408.
Longoni R, Cadoni C, Mulas A, Di Chiara G and Spina L (1998) Dopamine-dependent
behavioural stimulation by non-peptide delta opioid BW373U86 and SNC 80: 2.
Place preference and brain microdialysis in rats. Behav Pharmacol 9:9–14.
Lord JA, Waterfield AA, Hughes J and Kosterlitz HW (1977) Endogenous opioid
peptides: multiple agonists and receptors. Nature (Lond) 267:495–499.
Lorens SA (1976) Comparison of the effects of morphine on hypothalamic and medial
frontal cortex self-stimulation in the rat. Psychopharmacology 48:217–224.
Lorens SA and Mitchell CL (1973) Influence of morphine on lateral hypothalamic
self-stimulation in the rat. Psychopharmacologia 32:271–277.
Lukas SE, Brady JV and Griffiths RR (1986) Comparison of opioid self-injection and
disruption of schedule-controlled performance in the baboon. J Pharmacol Exp
Ther 238:924–931.
Lukas SE, Mello NK, Drieze JM and Mendelson JH (1995) Buprenorphine-induced
alterations of cocaine’s reinforcing effects in rhesus monkey: A dose-response
analysis. Drug Alcohol Depend 40:87–98.
Lyupina YV, Sudakov SK and Yarygin VN (1996) Inhibitors of Ca(2)-dependent
endopeptidases modulate morphine-induced effects in rats. Eur J Pharmacol
304:23–27.
Macht DI (1915) The history of opium and some of its preparations and alkaloids.
J Am Med Assoc 64:477–481.
Mackey WB and Van der Kooy D (1985) Neuroleptics block the positive reinforcing
effects of amphetamine but not of morphine as measured by place conditioning.
Pharmacol Biochem Behav 22:101–105.
Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP and Borrelli E (1997)
Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature
(Lond) 388:586–589.
Mannalack DT, Beart PM and Gundlach AL (1986) Psychotomimetic -opiates and
PCP. Trends Pharmacol Sci 7:448–451.
Marfaing-Jallat P, Miceli D and Le Magnen J (1983) Decrease in ethanol consumption
by naloxone in naive and dependent rats. Pharmacol Biochem Behav 18
(Suppl 1):537–539.
Marglin SH, MacKechnie DK, Mattie ME, Hui YH and Reid LD (1988) Ethanol with
small doses of morphine establishes a conditioned place preference. Alcohol 5:309–
313.
Markou A, Weiss F, Gold LH, Caine SB, Schulteis G and Koob GF (1993) Animal
models of drug craving. Psychopharmacology 112:163–182.
Martellotta MC, Cossu G, Fattore L, Gessa GL, Fratta W (1998) Self-administration
of the cannabinoid receptor agonist WIN 55,212–2 in drug-naïve mice. Neuroscience
85:327–330.
Martellotta MC, Kuzmin A, Moglia P, Gessa GL and Fratta W (1994) Effects of the
calcium antagonist isradipine on cocaine intravenous self-administration in rats.
Psychopharmacology 113:378–380.
Martin A, Pilotto R, Singer G and Oei TP (1983) The suppression of ethanol selfinjection
by buprenorphine. Pharmacol Biochem Behav 19:985–986.
Martin TJ, Dworkin SI and Smith JE (1995) Alkylation of -opioid receptors by
-funaltrexamine in vivo: Comparison of the effects on in situ binding and heroin
self-administration in rats. J Pharmacol Exp Ther 272:1135–1140.
Martin TJ, Kim SA, Harris LS and Smith JE (1997) Potent reinforcing effects of
dihydroetorphine in rats. Eur J Pharmacol 324:141–145.